Evaluation of Radium-223 Dichloride in the Treatment of Castration-Resistant Prostate Adenocarcinoma with Symptomatic Bone Metastases

被引：0

作者：

Maestre-Cutillas, R. ^{[1
]}

Sanchez-Tornero, A. M. ^{[2
]}

Baz-Sanz, L. ^{[1
]}

Rubio-Fernandez, G. ^{[1
]}

Casas-Fernandez, L. ^{[2
]}

Romero-Otero, M. ^{[2
]}

Perez-Iruela, J. A. ^{[1
]}

机构：

[1] Hosp Univ Ramon Y Cajal, Madrid, Spain

[2] Hosp Clin Univ Valencia, Valencia, Spain

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

EP-0559

引用

页码：S652 / S652

页数：1

共 50 条

[1] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
Vogelzang, Nicholas J.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
[2] Radium-223 Dichloride: A Novel Treatment Option for Castration-Resistant Prostate Cancer Patients With Symptomatic Bone Metastases
McGann, Shane
Horton, Evan R.
ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 469 - 476
[3] Radium-223 dichloride in castration-resistant prostate cancer with symptomatic bone metastases: a guide to its use
Shirley M.
McCormack P.L.
Drugs & Therapy Perspectives, 2016, 32 (3) : 98 - 103
[4] RADIUM-223 DICHLORIDE (RADIUM-223) FOR THE TREATMENT OF PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER AND SYMPTOMATIC BONE METASTASES: THE ESSENTIAL ROLE OF NURSES IN PATIENT CARE AND MANAGEMENT
Curley, Tracy
Arauz, Gabrielle
Jensen, Trine
Wahba, Mona
Delacruz, Anthony
ONCOLOGY NURSING FORUM, 2014, 41 (02) : E115 - E115
[5] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Matt Shirley
Paul L. McCormack
Drugs, 2014, 74 : 579 - 586
[6] Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Shirley, Matt
McCormack, Paul L.
DRUGS, 2014, 74 (05) : 579 - 586
[7] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
Sanchez Lopez, Hector
GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
[8] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
Nilsson, Sten
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
[9] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
Hiroji Uemura
Hirotsugu Uemura
Nobuaki Matsubara
Seigo Kinuya
Makoto Hosono
Yoko Yajima
Toshihiko Doi
International Journal of Clinical Oncology, 2017, 22 : 954 - 963
[10] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
Gallicchio, Rosj
Mastrangelo, Pietro A.
Nardelli, Anna
Mainenti, Pier Paolo
Colasurdo, Antonio P.
Landriscina, Matteo
Guglielmi, Giuseppe
Storto, Giovanni
TUMORI JOURNAL, 2019, 105 (05): : 367 - 377

← 1 2 3 4 5 →